{"id":"cdh6","name":"CDH6","symbol":"CDH6","route":"/targets/cdh6/","asOf":"2026-09-04","xrefs":[{"hgnc":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:1765","ensembl":"https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000113361","uniprot":"https://www.uniprot.org/uniprotkb/P55285/entry","alphafold-db":"https://alphafold.ebi.ac.uk/entry/P55285","open-targets":"https://platform.opentargets.org/target/ENSG00000113361","civic":"https://civicdb.org/genes/1004/summary","oncokb":"https://www.oncokb.org/gene/CDH6","cosmic":"https://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=CDH6","cbioportal":"https://www.cbioportal.org/results/mutations?cancer_study_list=msk_impact_2017&gene_list=CDH6","depmap":"https://depmap.org/portal/gene/CDH6?tab=overview","human-protein-atlas":"https://www.proteinatlas.org/ENSG00000113361-CDH6","ncbi-gene":"https://www.ncbi.nlm.nih.gov/gene/1004","omim":"https://www.omim.org/entry/603007"}],"products":[{"id":"raludotatug-deruxtecan","name":"Raludotatug deruxtecan","status":"phase-3","modality":"ADC","route":"/drugs/raludotatug-deruxtecan/"}],"trials":[{"id":"rejoice-ovarian01","name":"REJOICE-Ovarian01","nct":"NCT06161025","phase":"2/3","status":"recruiting"},{"id":"nct06780085","name":"A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)","nct":"NCT06780085","phase":"2","status":"recruiting"},{"id":"nct06864169","name":"A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)","nct":"NCT06864169","phase":"2","status":"active"},{"id":"nct06660654","name":"A Study of Raludotatug Deruxtecan in Participants With Advanced/Metastatic Solid Tumors (REJOICE-PanTumor01)","nct":"NCT06660654","phase":"2","status":"active"},{"id":"nct06843447","name":"A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)","nct":"NCT06843447","phase":"1/2","status":"recruiting"}],"pathways":[],"companies":["daiichi-sankyo","merck"],"keyPapers":[],"hotspots":[],"openQuestions":[],"assays":[],"resistance":[],"licence":"CC BY-NC 4.0, attribution to OnCo (https://onco.cc); commercial use needs a licence"}